Rizwan Romee

Dr. Romee is a translational physician-scientist at Dana Farber Cancer Institute, Harvard Medical School. His long-term research goals are to translate novel aspects of immunology to improve treatments for patients with advanced cancer. He did his medical training at University of Minnesota and Washington University and was a faculty at Washington University before joining Dana Farber. He is the PI of Romee Lab for NK Cell Gene Manipulation and Therapy (https://romeelab.dana-farber.org) and the focus of his lab is gene editing of the immune cells particularly NK cells to enhance their cancer cell targeting and killing. His work helped describe memory-like NK cells which have enhanced activity against cancer cells and persist for months after their infusion into leukemia patients. He is leading efforts at Dana Farber to develop novel protocols using memory-like NK cells with other immunomodulating agents like checkpoint inhibitors in patients with advanced and otherwise incurable leukemia and solid tumors like Head and Neck Cancer, Ovarian Cancer and Kidney Cancer.